Ajovy 225 MG/1.5 ML autoinject 1.5ML
Ended Awarded
- Contract number
- SPE2DB25FNBLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,293
Award facts
- Contract value 100% obligated
- $1,293.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,293.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ajovy (fremanezumab) 225 mg/1.5 ml auto-injector units. This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen operates under a significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the company to supply pharmaceutical products and medical supplies to military and federal healthcare systems globally.
This delivery order represents a routine procurement action under AmerisourceBergen's comprehensive prime IDV with DLA, which covers a broad spectrum of pharmaceutical products across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. The company's federal contract portfolio demonstrates its established capability to fulfill competitive federal medical procurement requirements consistently. The Ajovy auto-injector delivery supports the Defense Health Agency and broader military healthcare programs, reflecting the company's ongoing role as a strategic pharmaceutical supplier for federal defense and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FNBLM?
SPE2DB25FNBLM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FNBLM worth?
The government has obligated $1,293 on SPE2DB25FNBLM.
Is contract SPE2DB25FNBLM an order under another contract?
Yes. SPE2DB25FNBLM is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNBLM competed?
The extent of competition for SPE2DB25FNBLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award